These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15043468)
1. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Sarantopoulos GP; Gui D; Shintaku P; Hong L; Wang YY; Yap CS; Fishbein MC Arch Pathol Lab Med; 2004 Apr; 128(4):406-14. PubMed ID: 15043468 [TBL] [Abstract][Full Text] [Related]
2. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Goldstein NS; Thomas M Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157 [TBL] [Abstract][Full Text] [Related]
3. Bronchioloalveolar differentiation in lung adenocarcinomas. Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833 [TBL] [Abstract][Full Text] [Related]
4. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
5. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. Lau SK; Desrochers MJ; Luthringer DJ Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Saad RS; Cho P; Silverman JF; Liu Y Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373 [TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
9. Ovarian metastasis originating from bronchioloalveolar carcinoma: a rare presentation of lung cancer. Yeh KY; Chang JW; Hsueh S; Chang TC; Lin MC Jpn J Clin Oncol; 2003 Aug; 33(8):404-7. PubMed ID: 14523061 [TBL] [Abstract][Full Text] [Related]
10. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene. Sato K; Ueda Y; Shikata H; Katsuda S Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718 [TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119 [TBL] [Abstract][Full Text] [Related]
13. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Xu L; Tavora F; Battafarano R; Burke A Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010 [TBL] [Abstract][Full Text] [Related]
14. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464 [TBL] [Abstract][Full Text] [Related]
15. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541 [TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
17. Minimally invasive adenocarcinomas of the lung. Dacic S Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880 [TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinoma: a review of current concepts and evolving issues. Yousem SA; Beasley MB Arch Pathol Lab Med; 2007 Jul; 131(7):1027-32. PubMed ID: 17616987 [TBL] [Abstract][Full Text] [Related]